
Basaglar Kwikpen
My Prescription
Payment
Select pharmacy




$68.14
Print or send this coupon to your phone
About Basaglar Kwikpen
Drug Details
Insulin glargine is a medication used to manage high blood sugar in individuals with diabetes, in conjunction with a balanced diet and exercise. By controlling blood sugar levels, it helps prevent complications such as kidney damage, vision loss, nerve damage, amputations, and sexual dysfunction. It also reduces the risk of heart attacks and strokes. Insulin glargine is a synthetic form of insulin that mimics the natural insulin produced by the body. It works by facilitating the movement of glucose into cells for energy, maintaining a consistent, prolonged insulin level compared to regular insulin. It can be used on its own, with shorter-acting insulin, or alongside other diabetes medications. This information applies to insulin glargine and its variants, including insulin glargine-aglr and insulin glargine-yfgn.
Price history for Basaglar Kwikpen
1 Pen, 3ML of 100UNIT/ML
Average retail price for Basaglar Kwikpen
Average SaveHealth price for Basaglar Kwikpen
Our price history data is based on aggregated prescription data collected from participating pharmacies in America. Our prescription data updates daily to reflect the latest price changes. If you notice a missing data point, it means there wasn't sufficient data available to generate a monetary value for that date.
*Retail prices are based on pharmacy claims data, and may not be accurate when we don't have enough claims.
Basaglar Kwikpen dosage forms
| Dosage | Quantity | Price from | Per unit |
|---|---|---|---|
| 3ML of 100UNIT/ML | 1 Pen | $69.00 | $69.00 |
| 3ML of 100UNIT/ML | 2 Pens | $133.00 | $66.50 |
| 3ML of 100UNIT/ML | 3 Pens | $197.01 | $65.67 |
Basaglar Kwikpen FAQs
Basaglar KwikPen is a long-acting insulin.
Basaglar and Lantus are both long-acting insulin analogs used to control blood sugar levels in individuals with diabetes. They contain the same active ingredient, insulin glargine, and have similar effects in terms of onset, peak, and duration of action. However, they are not considered identical because they are produced by different manufacturers and may have differences in their formulation or delivery devices. It is important for patients to follow their healthcare provider's guidance when switching between these medications.
Basaglar KwikPen and Lantus are both long-acting insulin analogs used to control blood sugar levels in individuals with diabetes. While they have similar effects and are used in similar ways, they are not identical. Basaglar is considered a "follow-on" insulin to Lantus, meaning it is similar but not a generic version. They may have slight differences in formulation, but they are often used interchangeably in clinical practice. It is important for patients to follow their healthcare provider's guidance when switching between these insulins.
Basaglar, a long-acting insulin, should not be taken by individuals who have had an allergic reaction to insulin glargine or any of its ingredients. It is also not recommended for those experiencing episodes of hypoglycemia (low blood sugar). Additionally, patients with certain medical conditions or those taking specific medications should consult their healthcare provider to ensure Basaglar is safe for them. Pregnant or breastfeeding individuals should also discuss potential risks and benefits with their doctor.
Basaglar is a long-acting insulin. It is used to help control blood sugar levels in individuals with diabetes.